SCHEMBL3346925

SCHEMBL3346925

Cc1cnn(-c2ccc(C)c(N)c2)c(=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
KMT2A Q03164 5/20 0.42
KDM4E B2RXH2 4/20 0.42
MEN1 O00255 3/20 0.42
NPSR1 Q6W5P4 3/20 0.42
ALDH1A1 P00352 8/20 0.40
TDP1 Q9NUW8 2/20 0.40
RAB9A P51151 7/20 0.38
NPC1 O15118 6/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
MCL1 Q07820 1/20 0.36
CASP1 P29466 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
XBP1 P17861 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346920 0.80 RAB9A (0.45) MAPTKDM4EALDH1A1TDP1RAB9A
SCHEMBL3342526 0.79 P2RX7 (0.40) MAPTKMT2AKDM4EMEN1NPSR1
SCHEMBL3343676 0.78 CA12 (0.51) MAPTKMT2AKDM4EMEN1NPSR1
SCHEMBL3348736 0.76 P2RX7 (0.48) MAPTKMT2AKDM4EMEN1NPSR1
SCHEMBL3346722 0.76 P2RX7 (0.44) MAPTKMT2AKDM4EMEN1NPSR1
SCHEMBL18442921 0.76 NPC1 (0.59) MAPTKMT2AKDM4EMEN1NPSR1
SCHEMBL19286603 0.75 ALDH1A1 (0.53) MAPTKMT2AMEN1NPSR1ALDH1A1
SCHEMBL10767724 0.73 RAB9A (0.50) MAPTKMT2AMEN1NPSR1ALDH1A1
SCHEMBL3342953 0.73 ALDH1A1 (0.47) MAPTKMT2AKDM4EMEN1NPSR1
SCHEMBL3342293 0.73 HSD17B10 (0.34) KMT2AMEN1RAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 MAPT 2598/4885KMT2A 3250/4885KDM4E 2591/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 MAPT 4154/4885KMT2A 3668/4885KDM4E 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.